Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Rexahn Pharmaceuticals Company Profile (NYSE:RNN)

Consensus Ratings for Rexahn Pharmaceuticals (NYSE:RNN) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $3.25 (351.95% upside)

Analysts' Ratings History for Rexahn Pharmaceuticals (NYSE:RNN)
Show:
DateFirmActionRatingPrice TargetDetailsShare
9/16/2014LaidlawInitiated CoverageBuy$3.50ViewTweet This Rating  Share This Rating on StockTwits
3/24/2014Brinson PatrickInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
1/9/2014Roth CapitalInitiated CoverageBuy$3.00ViewTweet This Rating  Share This Rating on StockTwits
1/30/2013Maxim GroupInitiated CoverageBuy$1.50ViewTweet This Rating  Share This Rating on StockTwits
12/28/2012Burrill Institutional ResearchInitiated CoverageOutperform$1.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/31/2012 forward)
Discuss Rexahn Pharmaceuticals